EUVIMEDSkopri EUVIMED
Crossref

The Uptake of the Influenza Vaccine in Patients With Cystic Fibrosis: A Retrospective Study

Sarah Greenslade iD, Andrew Tai

Journal of Paediatrics and Child Health · 2025

DOI: 10.1111/jpc.16773 ↗

At a glance

Journal article in Journal of Paediatrics and Child Health, 2025. Written by Sarah Greenslade and 1 co-authors. Institution: Paediatric Respiratory and Sleep Department, Women's and Children's Hospital, Adelaide, South Australia, Australia. Major MEDLINE topics: Cystic Fibrosis, Influenza Vaccines, Influenza, Human, Vaccination Coverage. 17 references.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Background

Children with cystic fibrosis are more likely to become severely unwell with influenza‐associated illness compared to children without chronic lung disease. The provision of accessible influenza vaccinations is essential in the prevention of infection.

Objectives

To describe the prevalence of the influenza vaccine uptake in children with cystic fibrosis from 2016 to 2020 at a single tertiary paediatric hospital site and determine if the COVID pandemic of 2020 and the introduction of telehealth encounters affected the vaccine uptake.

Methods

A retrospective study of children with cystic fibrosis aged 6 months to 18 years who reside in South Australia was performed using the Women's and Children's Hospital (WCH) Respiratory Department cystic fibrosis database from 2016 to 2020. The Australian Immunisation Register (AIR) was used to determine vaccination status during this period.

Results

One hundred and eighty two children with cystic fibrosis were identified, one hundred and seventy two of whom vaccination records were available on the Australian Immunisation Register. Proportion of eligible patients who were vaccinated ranged from 66% to 88% in the years 2016–2019. There was no significant decrease in uptake during the COVID‐19 pandemic in 2020 (75%). Despite the introduction of Telehealth reviews in 2020 majority (66%) of patients continued to have exclusive face‐to‐face appointments, of which 73% received the vaccination. Vaccination coverage of those who received combination of Telehealth and face‐to‐face was 81%.

Conclusion

The high influenza vaccination rate of South Australian children with cystic fibrosis is consistent with rates seen in other tertiary centres globally. This study demonstrated that the pandemic and introduction of Telehealth appointments did not have any impact in the uptake of the influenza vaccination in our South Australian population.

Subjects

MeSH terms (MEDLINE)

Cystic FibrosisInfluenza VaccinesInfluenza, HumanVaccination CoverageHumansRetrospective StudiesChildAdolescentFemaleMaleChild, PreschoolInfantSouth AustraliaCOVID-19AustraliaTelemedicine

Author keywords

COVID‐19cystic fibrosisimmunisationinfluenzapandemicvaccination

Substances

Influenza Vaccines

Authors and institutions

  • Paediatric Respiratory and Sleep Department, Women's and Children's Hospital, Adelaide, South Australia, Australia.
  • Discipline of Paediatrics, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, Australia.

ORCID profiles: Sarah Greenslade

Cite

APA

Greenslade, S., & Tai, A. (2025). The Uptake of the Influenza Vaccine in Patients With Cystic Fibrosis: A Retrospective Study. Journal of Paediatrics and Child Health. https://doi.org/10.1111/jpc.16773

Vancouver

Greenslade S, Tai A. The Uptake of the Influenza Vaccine in Patients With Cystic Fibrosis: A Retrospective Study. Journal of Paediatrics and Child Health. 2025. doi:10.1111/jpc.16773

BibTeX
@article{Greenslade2025,
  author = {Greenslade, Sarah and Tai, Andrew},
  title = {The Uptake of the Influenza Vaccine in Patients With Cystic Fibrosis: A Retrospective Study},
  journal = {Journal of Paediatrics and Child Health},
  year = {2025},
  doi = {10.1111/jpc.16773}
}
Start for free →